Endra Life Sciences Stock Today

NDRA Stock  USD 6.05  0.21  3.60%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 79

 
High
 
Low
High
ENDRA Life is trading at 6.05 as of the 29th of November 2024, a 3.60 percent increase since the beginning of the trading day. The stock's open price was 5.84. ENDRA Life has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for ENDRA Life Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of August 2024 and ending today, the 29th of November 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
9th of May 2017
Category
Healthcare
Classification
Health Care
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. Endra Life operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 536.91 K outstanding shares of which 62.58 K shares are now shorted by private and institutional investors with about 0.05 trading days to cover. More on ENDRA Life Sciences

Moving against ENDRA Stock

  0.68DOCS Doximity Sell-off TrendPairCorr
  0.68ELMD ElectromedPairCorr
  0.55OM Outset MedicalPairCorr
  0.46MD Mednax IncPairCorr
  0.38GH Guardant HealthPairCorr
  0.35VREX Varex Imaging CorpPairCorr

ENDRA Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Acting ChairmanAlexander Tokman
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover9.0E-40.001
Notably Down
Slightly volatile
Gross Profit Margin0.580.5086
Fairly Up
Very volatile
Total Current Liabilities1.2 M903.1 K
Significantly Up
Slightly volatile
Total Assets6.6 M6.8 M
Fairly Down
Slightly volatile
Total Current Assets5.7 MM
Way Up
Slightly volatile
Debt Levels
ENDRA Life can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand ENDRA Life's financial leverage. It provides some insight into what part of ENDRA Life's total assets is financed by creditors.
Liquidity
ENDRA Life Sciences currently holds 394.4 K in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. ENDRA Life Sciences has a current ratio of 9.45, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ENDRA Life's use of debt, we should always consider it together with its cash and equity.

Sale Purchase Of Stock

13.93 Million
ENDRA Life Sciences (NDRA) is traded on NASDAQ Exchange in USA. It is located in 3600 Green Court, Ann Arbor, MI, United States, 48105-1570 and employs 21 people. ENDRA Life is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.25 M. ENDRA Life Sciences conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 536.91 K outstanding shares of which 62.58 K shares are now shorted by private and institutional investors with about 0.05 trading days to cover. ENDRA Life Sciences currently holds about 11.28 M in cash with (9.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18.
Check ENDRA Life Probability Of Bankruptcy
Ownership Allocation
Roughly 99.23 percent of ENDRA Life outstanding shares are held by general public with 0.28 (percent) owned by insiders and only 0.49 % by other corporate entities.
Check ENDRA Ownership Details

ENDRA Stock Institutional Holders

InstituionRecorded OnShares
Fmr Inc2024-06-30
0.0
Vanguard Group Inc2024-09-30
0.0
Geode Capital Management, Llc2024-09-30
0.0
Virtu Financial Llc2024-06-30
0.0
Xtx Topco Ltd2024-09-30
0.0
Two Sigma Securities, Llc2024-06-30
0.0
Northwestern Mutual Wealth Management Co2024-06-30
0.0
Hrt Financial Llc2024-06-30
329.6 K
Jane Street Group Llc2024-06-30
116.9 K
Ubs Group Ag2024-06-30
55.5 K
Susquehanna International Group, Llp2024-06-30
37.8 K
View ENDRA Life Diagnostics

ENDRA Life Historical Income Statement

At present, ENDRA Life's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Total Other Income Expense Net is expected to grow to about 483.5 K, whereas Interest Expense is forecasted to decline to about 23.5 K. View More Fundamentals

ENDRA Stock Against Markets

ENDRA Life Corporate Management

Michael ThorntonChief OfficerProfile
Renaud MalobertiChief Commercial OfficerProfile
Ziad RouagHead AffairsProfile
Jonathan BehrCoFounderProfile
Richard JacrouxChief OfficerProfile
When determining whether ENDRA Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ENDRA Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Endra Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Endra Life Sciences Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
-3 K
Return On Assets
(0.61)
Return On Equity
(1.20)
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.